Pathogenesis of enteric Salmonella infections

被引:108
作者
Grassl, Guntram A. [1 ]
Finlay, B. Brett [1 ,2 ]
机构
[1] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada
关键词
enterocolitis; inflammation; microbiota; Salmonella;
D O I
10.1097/MOG.0b013e3282f21388
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review Gastrointestinal disease caused by Salmonella species leads to significant morbidity and mortality worldwide. The use of various animal models has greatly advanced understanding of Salmonella pathogenesis at intestinal and systemic sites. This review will emphasize recent advances in the understanding of intestinal Salmonella infections. Recent findings Recent research has focused on bacterial products and the host pathogen recognition receptors involved in the activation of immune pathways. In particular, activation of Toll-like receptor 5 and lpaf by Salmonella flagellin has been a major finding The discovery. of cryptopatches as novel lymphoid follicles and the characterization of intestinal dendritic cell populations have been examined in the context of Salmonella infections. The development and use of the streptomycin pretreated mouse model of enterocolitis has allowed researchers to probe the host factors contributing to intestinal immunopathology. Furthermore, the analysis of microbiota in Salmonella infections has provided new insights regarding the role of inflammation in gastrointestinal diseases. In addition, the contributions of specific Salmonella type 3-secreted effectors to the establishment and modulation of inflammation have been further refined. Summary New advances in animal models have allowed researchers to further define the contribution of specific bacterial and host factors involved in Salmonella-induced enterocolitis.
引用
收藏
页码:22 / 26
页数:5
相关论文
共 45 条
[1]   Pretreatment of mice with streptomycin provides a Salmonella enterica serovar typhimurium colitis model that allows analysis of both pathogen and host [J].
Barthel, M ;
Hapfelmeier, S ;
Quintanilla-Martínez, L ;
Kremer, M ;
Rohde, M ;
Hogardt, M ;
Pfeffer, K ;
Rüssmann, H ;
Hardt, WD .
INFECTION AND IMMUNITY, 2003, 71 (05) :2839-2858
[2]  
BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030
[3]   Salmonella enterica serovar Typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function [J].
Boyle, Erin C. ;
Brown, Nat F. ;
Finlay, B. Brett .
CELLULAR MICROBIOLOGY, 2006, 8 (12) :1946-1957
[4]   Salmonella pathogenicity island 2 is expressed prior to penetrating the intestine [J].
Brown, Nat F. ;
Vallance, Bruce A. ;
Coombes, Brian K. ;
Valdez, Yanet ;
Coburn, Bryan A. ;
Finlay, B. Brett .
PLOS PATHOGENS, 2005, 1 (03) :252-258
[5]   Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: Central role of epithelial-derived MMP [J].
Castaneda, FE ;
Walia, B ;
Vijay-Kumar, M ;
Patel, NR ;
Roser, S ;
Kolachala, VL ;
Rojas, M ;
Wang, LX ;
Oprea, G ;
Garg, P ;
Gewirtz, AT ;
Roman, J ;
Merlin, D ;
Sitaraman, SV .
GASTROENTEROLOGY, 2005, 129 (06) :1991-2008
[6]   Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis [J].
Coburn, B ;
Li, YL ;
Owen, D ;
Vallance, BA ;
Finlay, BB .
INFECTION AND IMMUNITY, 2005, 73 (06) :3219-3227
[7]   Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine heal loop model and a murine model of infectious enterocolitis [J].
Coombes, BK ;
Coburn, BA ;
Potter, AA ;
Gomis, S ;
Mirakhur, K ;
Li, YL ;
Finlay, BB .
INFECTION AND IMMUNITY, 2005, 73 (11) :7161-7169
[8]   In vivo, fliC expression by Salmonella enterica serovar Typhimurium is heterogeneous, regulated by ClpX, and anatomically restricted [J].
Cummings, Lisa A. ;
Wilkerson, W. David ;
Bergsbaken, Tessa ;
Cookson, Brad T. .
MOLECULAR MICROBIOLOGY, 2006, 61 (03) :795-809
[9]   Innate recognition of intracellular bacteria [J].
Delbridge, Laura M. ;
O'Riordan, Mary X. D. .
CURRENT OPINION IN IMMUNOLOGY, 2007, 19 (01) :10-16
[10]  
FINK SL, 2007, CELL MICROBIOL